drugset / Trial / NCT00840866
Cefprozil 500 mg Tablets Under Fed Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to compare the relative bioavailability of cefprozil 500 mg tablets with that of Cefzil 500 mg tablets in healthy, non-smoking adults under non-fasting conditions.
Timeline
- Start
- 2003-09
- Primary completion
- 2003-09
- Completion
- 2003-09
Outcome
Met primary endpoint
registry Ratio of the T/R geometric mean x 100 104 (90% CI 99 to 109) NCT00840866 ↗
registry Ratio of the T/R geometric mean x 100 99.9 (90% CI 98.6 to 101) NCT00840866 ↗
registry Ratio of the T/R geometric mean x 100 99.8 (90% CI 98.5 to 101) NCT00840866 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CEFPROZIL ANHYDROUS, (E)- | Small molecule | 500 mg | — |
Indications
No indication recorded.